Literature DB >> 25208230

Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH.

A A Khorana1, H-M Otten, J I Zwicker, G C Connolly, D F Bancel, I Pabinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25208230     DOI： 10.1111/jth.12725

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  21 in total

1.  Primary venous thromboembolism prophylaxis in patients with solid tumors.

Authors:  A Casanegra; A Mansfield; A Tafur
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

Review 2.  Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?

Authors:  Ingrid Pabinger; Julia Riedl
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.

Authors:  Tzu-Fei Wang; Jeffrey I Zwicker; Cihan Ay; Ingrid Pabinger; Anna Falanga; Darko Antic; Simon Noble; Alok A Khorana; Marc Carrier; Guy Meyer
Journal:  J Thromb Haemost       Date:  2019-07-28       Impact factor: 5.824

Review 4.  Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review.

Authors:  Hanno Riess; Piet Habbel; Anja Jühling; Marianne Sinn; Uwe Pelzer
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

5.  Physicians' decision about long-term thromboprophylaxis in cancer outpatients: CAT AXIS, a case vignette study on clinical practice in France.

Authors:  Florian Scotté; I Elalamy; D Mayeur; G Meyer
Journal:  Support Care Cancer       Date:  2018-01-20       Impact factor: 3.603

Review 6.  New insights into genotype and phenotype of VWD.

Authors:  Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

Review 7.  Safety and efficacy of primary thromboprophylaxis in cancer patients.

Authors:  I García Escobar; M Antonio Rebollo; S García Adrián; A Rodríguez-Garzotto; A Muñoz Martín
Journal:  Clin Transl Oncol       Date:  2016-05-04       Impact factor: 3.405

8.  Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist's impact on anticoagulant therapy.

Authors:  Esin Aysel Kandemir; Aygin Bayraktar-Ekincioglu; Saadettin Kilickap
Journal:  Support Care Cancer       Date:  2020-08-10       Impact factor: 3.603

9.  Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.

Authors:  Floris T M Bosch; Frits I Mulder; Pieter Willem Kamphuisen; Saskia Middeldorp; Patrick M Bossuyt; Harry R Büller; Nick van Es
Journal:  Blood Adv       Date:  2020-10-27

10.  Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.

Authors:  Ryan Pelletier
Journal:  J Oncol Pharm Pract       Date:  2021-03-24       Impact factor: 1.809
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.